These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27067966)

  • 1. Management of recurrent venous thromboembolism in cancer patients.
    Romualdi E; Ageno W
    Thromb Res; 2016 Apr; 140 Suppl 1():S128-31. PubMed ID: 27067966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of venous thromboembolism in cancer patients.
    Petralia GA; Kakkar AK
    Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
    Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M;
    Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention of venous thromboembolism in patients with cancer].
    Meyer G
    Rev Prat; 2011 Nov; 61(9):1249-51. PubMed ID: 22308809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Cancer-Associated Venous Thromboembolism in the Emergency Department.
    Nene RV; Coyne CJ
    Ann Emerg Med; 2017 Jun; 69(6):768-776. PubMed ID: 28169053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of recurrent venous thromboembolism in patients with cancer: A review.
    Piran S; Schulman S
    Thromb Res; 2018 Apr; 164 Suppl 1():S172-S177. PubMed ID: 29703478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMWH in cancer patients with renal impairment - better than warfarin?
    Bauersachs RM
    Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of anticoagulation therapy for venous thromboembolism.
    Bounameaux H; Perrier A
    Hematology Am Soc Hematol Educ Program; 2008; ():252-8. PubMed ID: 19074092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Venous thromboembolism and cancer].
    Meyer G
    Rev Prat; 2015 Feb; 65(2):216-9. PubMed ID: 25939227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
    Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
    J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
    Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
    J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on diagnosis and anticoagulant therapy for venous thromboembolism.
    Stevens H; Tran H
    Intern Med J; 2018 Oct; 48(10):1175-1184. PubMed ID: 30288893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.
    Dranitsaris G; Shane LG; Woodruff S
    J Oncol Pharm Pract; 2019 Jan; 25(1):68-75. PubMed ID: 28857713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
    Tran QN
    Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
    Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
    J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of venous thromboembolism in patients with cancer.
    Prandoni P
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.